Skip to content

Clinical trials

Phase 3 Cystic Fibrosis trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cystic Fibrosis Phase: Phase 3 Country / region: Australia Clear all

57 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20053
20061
20071
20082
20092
20104
20121
20133
20142
20157
20162
20171
20188
20194
20204
20215
20224
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed50
Active, not recruiting3
Terminated3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Vertex Pharmaceuticals Incorporated43
Gilead Sciences3
PTC Therapeutics2
Syntara2
Amgen1
Boehringer Ingelheim1
Merck Sharp & Dohme LLC1
Neovii Biotech1
Novartis Pharmaceuticals1
Sydney Children's Hospitals Network1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cystic Fibrosis57
Pseudomonas Infections3
Bronchiectasis2
Fibrosis2
Genetic Diseases, Inborn2
Infant, Newborn, Diseases2
Lung Diseases2
Pancreatic Diseases2
Pathologic Processes2
Respiratory Tract Diseases2

Trials

Showing 1 to 25 of 57. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.